vs
Side-by-side financial comparison of AVIENT CORP (AVNT) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($1.3B vs $760.6M, roughly 1.8× AVIENT CORP). HAEMONETICS CORP runs the higher net margin — 7.3% vs 2.2%, a 5.1% gap on every dollar of revenue. On growth, HAEMONETICS CORP posted the faster year-over-year revenue change (4.8% vs 1.9%). HAEMONETICS CORP produced more free cash flow last quarter ($209.9M vs $125.4M). Over the past eight quarters, HAEMONETICS CORP's revenue compounded faster (99.2% CAGR vs -4.2%).
Avient Corporation is a global materials solutions company headquartered in Avon Lake, Ohio, United States, employing approximately 9,000 people worldwide. Its products include colorants, advanced composites, functional additives and engineered materials.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
AVNT vs HAE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2026
| Metric | | |
|---|---|---|
| Revenue | $760.6M | $1.3B |
| Net Profit | $16.9M | $97.3M |
| Gross Margin | 30.2% | 14.9% |
| Operating Margin | 5.2% | 83.4% |
| Net Margin | 2.2% | 7.3% |
| Revenue YoY | 1.9% | 4.8% |
| Net Profit YoY | -65.0% | -42.0% |
| EPS (diluted) | $0.18 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.3B | ||
| Q4 25 | $760.6M | $339.0M | ||
| Q3 25 | $806.5M | $327.3M | ||
| Q2 25 | $866.5M | $321.4M | ||
| Q1 25 | $826.6M | $330.6M | ||
| Q4 24 | $746.5M | $348.5M | ||
| Q3 24 | $815.2M | $345.5M | ||
| Q2 24 | $849.7M | $336.2M |
| Q1 26 | — | $97.3M | ||
| Q4 25 | $16.9M | $44.7M | ||
| Q3 25 | $32.6M | $38.7M | ||
| Q2 25 | $52.6M | $34.0M | ||
| Q1 25 | $-20.2M | $58.0M | ||
| Q4 24 | $48.3M | $37.5M | ||
| Q3 24 | $38.2M | $33.8M | ||
| Q2 24 | $33.6M | $38.4M |
| Q1 26 | — | 14.9% | ||
| Q4 25 | 30.2% | 59.7% | ||
| Q3 25 | 30.4% | 59.5% | ||
| Q2 25 | 32.1% | 59.8% | ||
| Q1 25 | 31.8% | 58.4% | ||
| Q4 24 | 34.8% | 55.5% | ||
| Q3 24 | 32.1% | 54.2% | ||
| Q2 24 | 30.3% | 52.0% |
| Q1 26 | — | 83.4% | ||
| Q4 25 | 5.2% | 19.9% | ||
| Q3 25 | 8.3% | 17.9% | ||
| Q2 25 | 11.1% | 16.8% | ||
| Q1 25 | 0.1% | 21.6% | ||
| Q4 24 | 11.5% | 16.9% | ||
| Q3 24 | 9.5% | 15.0% | ||
| Q2 24 | 8.5% | 11.8% |
| Q1 26 | — | 7.3% | ||
| Q4 25 | 2.2% | 13.2% | ||
| Q3 25 | 4.0% | 11.8% | ||
| Q2 25 | 6.1% | 10.6% | ||
| Q1 25 | -2.4% | 17.5% | ||
| Q4 24 | 6.5% | 10.8% | ||
| Q3 24 | 4.7% | 9.8% | ||
| Q2 24 | 4.0% | 11.4% |
| Q1 26 | — | — | ||
| Q4 25 | $0.18 | $0.95 | ||
| Q3 25 | $0.36 | $0.81 | ||
| Q2 25 | $0.57 | $0.70 | ||
| Q1 25 | $-0.22 | $1.17 | ||
| Q4 24 | $0.53 | $0.74 | ||
| Q3 24 | $0.41 | $0.66 | ||
| Q2 24 | $0.36 | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $245.4M |
| Total DebtLower is stronger | $1.9B | $1.2B |
| Stockholders' EquityBook value | $2.4B | $796.3M |
| Total Assets | $6.0B | $2.4B |
| Debt / EquityLower = less leverage | 0.81× | 1.53× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.4M | ||
| Q4 25 | — | $363.4M | ||
| Q3 25 | — | $296.4M | ||
| Q2 25 | — | $292.9M | ||
| Q1 25 | — | $306.8M | ||
| Q4 24 | — | $320.8M | ||
| Q3 24 | — | $299.3M | ||
| Q2 24 | — | $344.4M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $1.9B | $1.2B | ||
| Q3 25 | $2.0B | $1.2B | ||
| Q2 25 | $2.0B | $1.2B | ||
| Q1 25 | $2.1B | $1.2B | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — |
| Q1 26 | — | $796.3M | ||
| Q4 25 | $2.4B | $911.5M | ||
| Q3 25 | $2.4B | $849.2M | ||
| Q2 25 | $2.4B | $882.3M | ||
| Q1 25 | $2.3B | $820.8M | ||
| Q4 24 | $2.3B | $906.9M | ||
| Q3 24 | $2.4B | $878.9M | ||
| Q2 24 | $2.3B | $905.4M |
| Q1 26 | — | $2.4B | ||
| Q4 25 | $6.0B | $2.5B | ||
| Q3 25 | $6.1B | $2.4B | ||
| Q2 25 | $6.1B | $2.5B | ||
| Q1 25 | $5.8B | $2.5B | ||
| Q4 24 | $5.8B | $2.5B | ||
| Q3 24 | $6.0B | $2.5B | ||
| Q2 24 | $5.9B | $2.5B |
| Q1 26 | — | 1.53× | ||
| Q4 25 | 0.81× | 1.34× | ||
| Q3 25 | 0.83× | 1.44× | ||
| Q2 25 | 0.86× | 1.39× | ||
| Q1 25 | 0.90× | 1.49× | ||
| Q4 24 | 0.89× | — | ||
| Q3 24 | 0.88× | — | ||
| Q2 24 | 0.90× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $167.8M | $293.2M |
| Free Cash FlowOCF − Capex | $125.4M | $209.9M |
| FCF MarginFCF / Revenue | 16.5% | 15.7% |
| Capex IntensityCapex / Revenue | 5.6% | 2.5% |
| Cash ConversionOCF / Net Profit | 9.93× | 3.01× |
| TTM Free Cash FlowTrailing 4 quarters | $195.0M | $417.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $293.2M | ||
| Q4 25 | $167.8M | $93.6M | ||
| Q3 25 | $72.1M | $111.3M | ||
| Q2 25 | $112.8M | $17.4M | ||
| Q1 25 | $-51.1M | $116.6M | ||
| Q4 24 | $122.6M | $43.8M | ||
| Q3 24 | $71.1M | $48.8M | ||
| Q2 24 | $105.9M | $-27.4M |
| Q1 26 | — | $209.9M | ||
| Q4 25 | $125.4M | $87.2M | ||
| Q3 25 | $47.4M | $106.3M | ||
| Q2 25 | $85.8M | $13.6M | ||
| Q1 25 | $-63.6M | $100.9M | ||
| Q4 24 | $81.5M | $35.2M | ||
| Q3 24 | $46.1M | $39.4M | ||
| Q2 24 | $74.5M | $-33.1M |
| Q1 26 | — | 15.7% | ||
| Q4 25 | 16.5% | 25.7% | ||
| Q3 25 | 5.9% | 32.5% | ||
| Q2 25 | 9.9% | 4.2% | ||
| Q1 25 | -7.7% | 30.5% | ||
| Q4 24 | 10.9% | 10.1% | ||
| Q3 24 | 5.7% | 11.4% | ||
| Q2 24 | 8.8% | -9.8% |
| Q1 26 | — | 2.5% | ||
| Q4 25 | 5.6% | 1.9% | ||
| Q3 25 | 3.1% | 1.5% | ||
| Q2 25 | 3.1% | 1.2% | ||
| Q1 25 | 1.5% | 4.7% | ||
| Q4 24 | 5.5% | 2.5% | ||
| Q3 24 | 3.1% | 2.7% | ||
| Q2 24 | 3.7% | 1.7% |
| Q1 26 | — | 3.01× | ||
| Q4 25 | 9.93× | 2.09× | ||
| Q3 25 | 2.21× | 2.88× | ||
| Q2 25 | 2.14× | 0.51× | ||
| Q1 25 | — | 2.01× | ||
| Q4 24 | 2.54× | 1.17× | ||
| Q3 24 | 1.86× | 1.44× | ||
| Q2 24 | 3.15× | -0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNT
| Color Additives And Inks | $466.0M | 61% |
| Specialty Engineered Materials | $295.5M | 39% |
HAE
Segment breakdown not available.
